Paraneoplastic itch: An expert position statement from the special interest group (SIG) of the international forum on the study of itch (IFSI)

Elke Weisshaar, Melanie Weiss, Thomas Mettang, Gil Yosipovitch, Zbigniew Zylicz

Research output: Contribution to journalArticle

19 Citations (Scopus)

Abstract

In clinical practice, the term “paraneoplastic itch” is used to describe itch in patients with cancer. Patients with hematological or solid tumor malignancies can be affected. In general, paraneoplastic itch is considered a rare disorder. However, paraneoplastic itch in hematological malignancies such as polycythemia vera and lymphoma are relatively frequent while other forms of paraneoplastic itch are in fact extremely rare. The true frequency of this symptom is unclear, epidemiological data in this field are limited. Itch in malignant disease may additionally impair patients’ quality of life. A population- based cohort study showed that chronic itch without concomitant skin changes is a risk factor for having undiagnosed hematologic and bile duct malignancies. Paraneoplastic itch is rather resistant to treatment. In 2012, an interdisciplinary interest group of physicians and researchers was founded, aiming to generate a clear definition of paraneoplastic itch. In this paper we briefly review the current knowledge and aim to define what can be summarized under the term “paraneoplastic itch”.

Original languageEnglish (US)
Pages (from-to)261-265
Number of pages5
JournalActa Dermato-Venereologica
Volume95
Issue number3
DOIs
StatePublished - Jan 1 2015
Externally publishedYes

Fingerprint

Public Opinion
Neoplasms
Polycythemia Vera
Hematologic Neoplasms
Bile Ducts
Lymphoma
Cohort Studies
Quality of Life
Research Personnel
Physicians
Skin
Population
Therapeutics

Keywords

  • Cancer
  • Itch
  • Malignancy
  • Palliative care
  • Paraneoplastic itch
  • Pruritus

ASJC Scopus subject areas

  • Dermatology

Cite this

Paraneoplastic itch : An expert position statement from the special interest group (SIG) of the international forum on the study of itch (IFSI). / Weisshaar, Elke; Weiss, Melanie; Mettang, Thomas; Yosipovitch, Gil; Zylicz, Zbigniew.

In: Acta Dermato-Venereologica, Vol. 95, No. 3, 01.01.2015, p. 261-265.

Research output: Contribution to journalArticle

@article{82346f12c03744e78f8076c5711ff860,
title = "Paraneoplastic itch: An expert position statement from the special interest group (SIG) of the international forum on the study of itch (IFSI)",
abstract = "In clinical practice, the term “paraneoplastic itch” is used to describe itch in patients with cancer. Patients with hematological or solid tumor malignancies can be affected. In general, paraneoplastic itch is considered a rare disorder. However, paraneoplastic itch in hematological malignancies such as polycythemia vera and lymphoma are relatively frequent while other forms of paraneoplastic itch are in fact extremely rare. The true frequency of this symptom is unclear, epidemiological data in this field are limited. Itch in malignant disease may additionally impair patients’ quality of life. A population- based cohort study showed that chronic itch without concomitant skin changes is a risk factor for having undiagnosed hematologic and bile duct malignancies. Paraneoplastic itch is rather resistant to treatment. In 2012, an interdisciplinary interest group of physicians and researchers was founded, aiming to generate a clear definition of paraneoplastic itch. In this paper we briefly review the current knowledge and aim to define what can be summarized under the term “paraneoplastic itch”.",
keywords = "Cancer, Itch, Malignancy, Palliative care, Paraneoplastic itch, Pruritus",
author = "Elke Weisshaar and Melanie Weiss and Thomas Mettang and Gil Yosipovitch and Zbigniew Zylicz",
year = "2015",
month = "1",
day = "1",
doi = "10.2340/00015555-1959",
language = "English (US)",
volume = "95",
pages = "261--265",
journal = "Acta Dermato-Venereologica",
issn = "0001-5555",
publisher = "Society for the Publication of Acta Dermato-Venereologica",
number = "3",

}

TY - JOUR

T1 - Paraneoplastic itch

T2 - An expert position statement from the special interest group (SIG) of the international forum on the study of itch (IFSI)

AU - Weisshaar, Elke

AU - Weiss, Melanie

AU - Mettang, Thomas

AU - Yosipovitch, Gil

AU - Zylicz, Zbigniew

PY - 2015/1/1

Y1 - 2015/1/1

N2 - In clinical practice, the term “paraneoplastic itch” is used to describe itch in patients with cancer. Patients with hematological or solid tumor malignancies can be affected. In general, paraneoplastic itch is considered a rare disorder. However, paraneoplastic itch in hematological malignancies such as polycythemia vera and lymphoma are relatively frequent while other forms of paraneoplastic itch are in fact extremely rare. The true frequency of this symptom is unclear, epidemiological data in this field are limited. Itch in malignant disease may additionally impair patients’ quality of life. A population- based cohort study showed that chronic itch without concomitant skin changes is a risk factor for having undiagnosed hematologic and bile duct malignancies. Paraneoplastic itch is rather resistant to treatment. In 2012, an interdisciplinary interest group of physicians and researchers was founded, aiming to generate a clear definition of paraneoplastic itch. In this paper we briefly review the current knowledge and aim to define what can be summarized under the term “paraneoplastic itch”.

AB - In clinical practice, the term “paraneoplastic itch” is used to describe itch in patients with cancer. Patients with hematological or solid tumor malignancies can be affected. In general, paraneoplastic itch is considered a rare disorder. However, paraneoplastic itch in hematological malignancies such as polycythemia vera and lymphoma are relatively frequent while other forms of paraneoplastic itch are in fact extremely rare. The true frequency of this symptom is unclear, epidemiological data in this field are limited. Itch in malignant disease may additionally impair patients’ quality of life. A population- based cohort study showed that chronic itch without concomitant skin changes is a risk factor for having undiagnosed hematologic and bile duct malignancies. Paraneoplastic itch is rather resistant to treatment. In 2012, an interdisciplinary interest group of physicians and researchers was founded, aiming to generate a clear definition of paraneoplastic itch. In this paper we briefly review the current knowledge and aim to define what can be summarized under the term “paraneoplastic itch”.

KW - Cancer

KW - Itch

KW - Malignancy

KW - Palliative care

KW - Paraneoplastic itch

KW - Pruritus

UR - http://www.scopus.com/inward/record.url?scp=84922769492&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=84922769492&partnerID=8YFLogxK

U2 - 10.2340/00015555-1959

DO - 10.2340/00015555-1959

M3 - Article

C2 - 25179683

AN - SCOPUS:84922769492

VL - 95

SP - 261

EP - 265

JO - Acta Dermato-Venereologica

JF - Acta Dermato-Venereologica

SN - 0001-5555

IS - 3

ER -